Don’t let overhead kill your business
By Lee Schuh Many businesses consider overhead to be the No. 1 impediment to reaching their business goals. However, it isn’t overhead that is the problem but rather the results of poor planning for the future growth of the business. This is certainly true for companies growing relatively fast. We will use the term overhead Read More →
More than 2,500 people turn out for Latino Business Expo
More than 2,500 people from Ventura County attended the Latino Business Expo on Oct. 27 at the Ventura County Fairgrounds. The twice-a-year event featured exhibits from 122 businesses and nonprofits. Among the more popular displays were those for Tequila Alquimia and rival spirits maker Sin Rival — both were handing out free samples. Businesses in Read More →
Net income up at Community West Bancshares
Community West Bancshares said third quarter net income was $1.5 million, up from $1.1 million in the second quarter and on pace with year-earlier earnings. For the nine months ended Sept. 30, the bank reported net income of $3.9 million versus $1 million for the prior year; loans grew 12.9 percent to $601.9 million on Read More →
Merger of AT&T, Time Warner has a familiar ring
Thirty five years ago, I was a reporter for Springfield Newspapers in Massachusetts when AT&T was broken up and the era of the “Baby Bells” began. That era effectively ended this month when a reconstituted AT&T announced a $68 billion merger with Time Warner, the owner of Warner Brothers, HBO, CNN and other assets that Read More →
Deckers sales down but earnings up for second quarter
Deckers Brands, the Goleta-based footwear, apparel and accessories company, announced net sales of $485.9 million and earnings per diluted share of $1.21 for the second quarter ended Sept. 30. Sales were down slightly from $486.9 million for the same period last year, primarily for the company’s UGG and Teva brands, but earnings were up 9 Read More →
Amgen beats analysts’ revenue, earnings per share estimates
Amgen revenues increased 2 percent during the third quarter as it beat analysts’ revenue and earnings per share estimates thanks to cost-cutting measures and lower research measures. Revenues for the Thousand Oaks-based biotech giant increased from $5.72 billion during the third quarter of 2015 to $5.81 billion in 2016, which beat analyst estimates of $5.73 Read More →